- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07845721
Using Contact Lenses and Spectacle Lenses as Myopia Interventions.
Twelve-Month Outcomes in Children Using MiSight® 1-Day Contact Lenses and Myopia Control Spectacle Lenses as Complementary Myopia Control Interventions.
Effect of alternating contact lenses and spectacles for myopia control.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Baskar Arumugam, PhD
- Telefonnummer: 1(925) 353-8468
- E-post: barumugam@coopervision.com
Studiesteder
-
-
Ontario
-
Waterloo, Ontario, Canada, N2L 3Gi
- Centre for Ocular Research & Education (CORE) School of Optometry & Vision Science University of Waterloo
-
Ta kontakt med:
- Jill Woods
- Telefonnummer: 1-519 888 4567 ext 436743
- E-post: jwoods@uwaterloo.ca
-
Hovedetterforsker:
- Jill Woods
-
Hovedetterforsker:
- Deborah Jones
-
-
-
-
-
Birmingham, Storbritannia, B4 7ET
- Aston University
-
Ta kontakt med:
- Nicola Logan
- Telefonnummer: 0121 204 4128
- E-post: n.s.logan@aston.ac.uk
-
Hovedetterforsker:
- Nicola Logan
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Are aged 11 to 17 years (inclusive);
- Have successfully completed the 4-year MiSight® Analysis of Progression (MAP) Study;
- Are established soft contact lens wearers (including myopia control contact lens designs);
- Have read and signed the study consent or assent form, as appropriate for their age;
- Have a parent or legal guardian who has read and signed the Parent/Guardian Information Sheet (PIS) and Consent Form;
- Are willing and able to follow study instructions and maintain the appointment schedule;
- Are willing to wear the study contact lenses for 10 hours/day and 5 days per week as an ideal target while participating;
- Require a spherical contact lens power correction between -0.50 and -6.00 D;
- Have astigmatism not exceeding 2.00 DC in each eye by subjective refraction;
- Have best-corrected visual acuity of 0.10 logMAR (approx. 20/25 Snellen) or better in each eye;
- Have ocular health findings (biomicroscopy) that do not contraindicate contact lens wear;
- Continue to demonstrate acceptable fit and handling with the study contact lenses.
Exclusion Criteria:
- Are participating in any concurrent clinical or interventional study;
- Have worn rigid gas-permeable (including orthokeratology) contact lenses within the previous 30 days;
- Have used atropine concentrations above 0.01% for myopia control in the previous 30 days;
- Are extended-wear contact lens users (i.e., sleep in their lenses);
- Have best-corrected visual acuity worse than 0.10 logMAR in either eye;
- Have any current or evolving ocular or systemic condition that could affect visual function, ocular growth, or contact lens wear;
- Have any clinically significant corneal or conjunctival staining with sodium fluorescein, or other ocular findings contraindicating contact lens wear;
- Are using systemic or topical medications known or expected to affect pupil size, tear production, accommodation, refractive state, or any study outcome variable;
- Have a history of ocular surgery, keratoconus, or other forms of irregular cornea, or are aphakic;
- Have diagnosed accommodative and/or binocular vision anomalies, including amblyopia, strabismus, or nystagmus;
- Have known sensitivity or allergy to any of the diagnostic agents used in the study;
- Have any systemic condition that, in the opinion of the investigator, may influence study outcomes or contraindicate soft contact lens wear, including pregnancy;
- Are a child of an employee of either clinical site directly involved in the study.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Test Group
Participants will wear Test Spectacle Lens & Contact Lenses |
Participants will wear contact lenses for a target of 10 hours a day, 5 days per week and test spectacle lenses for remaining waking hours. |
|
Eksperimentell: Control Group
Participants will wear Control Spectacle Lens & Contact Lenses |
Participants will wear contact lenses for a target of 10 hours a day, 5 days per week and control spectacle lenses for remaining waking hours. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Change in axial length (AXL, mm) over 12 months
Tidsramme: Over 12 months
|
Over 12 months
|
Samarbeidspartnere og etterforskere
Samarbeidspartnere
Etterforskere
- Studiestol: Baskar Arumugam, PhD, CooperVision, Inc.
- Studiestol: Debbbie Laughton, SightGlass Vision, Inc.
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- CV-25-34
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
produkt produsert i og eksportert fra USA
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .